Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cunningham

Showing results (1341-1350 of 1,411) with videos related to

Pageof 142
Sort By:
Geroscience|February 14, 2025
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging ProjectAmanda E Coleman, Kate E Creevy, Rozalyn Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancerCeleste Leigh Pearce, Mary Anne Rossing, Alice W Lee, et al.
Oncotarget|February 6, 2016
A targeted genetic association study of epithelial ovarian cancer susceptibilityMadalene Earp, Stacey J Winham, Nicholas Larson, et al.
Plos Genetics|July 15, 2010
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Sharon E Johnatty, Jonathan Beesley, Xiaoqing Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
International Journal of Cancer|July 27, 2016
Telomere structure and maintenance gene variants and risk of five cancer typesSara Karami, Younghun Han, Mala Pande, et al.
Nature Genetics|February 12, 2008
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerJulius Gudmundsson, Patrick Sulem, Thorunn Rafnar, et al.
Pageof 142

Showing results (1341-1350 of 1,411) with videos related to

Sort By:
Pageof 142
Geroscience|February 14, 2025
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging ProjectAmanda E Coleman, Kate E Creevy, Rozalyn Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2013
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancerCeleste Leigh Pearce, Mary Anne Rossing, Alice W Lee, et al.
Oncotarget|February 6, 2016
A targeted genetic association study of epithelial ovarian cancer susceptibilityMadalene Earp, Stacey J Winham, Nicholas Larson, et al.
Plos Genetics|July 15, 2010
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Sharon E Johnatty, Jonathan Beesley, Xiaoqing Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
International Journal of Cancer|July 27, 2016
Telomere structure and maintenance gene variants and risk of five cancer typesSara Karami, Younghun Han, Mala Pande, et al.
Nature Genetics|February 12, 2008
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerJulius Gudmundsson, Patrick Sulem, Thorunn Rafnar, et al.
Pageof 142